Coronary Thrombosis and Major Bleeding after PCI with Drug-Eluting Stents Risk Scores from Paris

Journal of the American College of Cardiology

Volumn 67, Issue 19, 2016, Pages 2224-2234

  Baber, Usman ^a   Mehran, Roxana ^a   Giustino, Gennaro ^a   Cohen, David J ^b   Henry, Timothy D ^c   Sartori, Samantha ^a   Ariti, Cono ^d   Litherland, Claire ^e   Dangas, George ^a   Michael Gibson, C ^f   Krucoff, Mitchell W ^g   Moliterno, David J ^h   Kirtane, Ajay J ^e,i   Stone, Gregg W ^e,i   Colombo, Antonio ^j   Chieffo, Alaide ^j   Kini, Annapoorna S ^a   Witzenbichler, Bernhard ^k   Weisz, Giora ^l   Steg, Philippe Gabriel ^m   Pocock, Stuart ^d   more..

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

ⁱ NewYork Presbyterian Hospital   (United States)

^j SAN RAFFAELE HOSPITAL   (Italy)

^k Helios Amper Klinikum   (Germany)

^l SHAARE ZEDEK MEDICAL CENTER   (Israel)

^m UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

bleeding; PCI; risk; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANEMIA; ARTICLE; BLEEDING; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT HISTORY OF CORONARY ARTERY BYPASS GRAFT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; VERY ELDERLY; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION DRUG THERAPY; CORONARY THROMBOSIS; HEMORRHAGE; MEDICATION COMPLIANCE; MULTICENTER STUDY; REGISTER; RENAL INSUFFICIENCY; RISK ASSESSMENT; UNITED STATES;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; ANEMIA; ASPIRIN; BODY MASS INDEX; COHORT STUDIES; CORONARY THROMBOSIS; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RENAL INSUFFICIENCY; RISK ASSESSMENT; SMOKING; TICLOPIDINE; UNITED STATES;

EID: 84964370865     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.064     Document Type: Article

References (33)

1. G. Giustino, U. Baber, S. Sartori, and et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials J Am Coll Cardiol 65 2015 1298 1310
2. R. Mehran, G. Giustino, and U. Baber DAPT duration after DES: what is the "mandatory" duration? J Am Coll Cardiol 65 2015 1103 1106
3. R. Mehran, S.J. Pocock, E. Nikolsky, and et al. A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
4. A. Halkin, M. Singh, E. Nikolsky, and et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score J Am Coll Cardiol 45 2005 1397 1405
5. G.D. Dangas, B.E. Claessen, R. Mehran, and et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes J Am Coll Cardiol Intv 5 2012 1097 1105
6. T. Palmerini, P. Genereux, A. Caixeta, and et al. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score J Am Coll Cardiol Intv 5 2012 1108 1116
7. S. Subherwal, R.G. Bach, A.Y. Chen, and et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) bleeding score Circulation 119 2009 1873 1882
8. E.D. Peterson, D. Dai, E.R. DeLong, and et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry J Am Coll Cardiol 55 2010 1923 1932
9. E.M. Antman, M. Cohen, P.J. Bernink, and et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
10. E. Boersma, K.S. Pieper, E.W. Steyerberg, et al. for the PURSUIT Investigators Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients Circulation 101 2000 2557 2567
11. D.A. Morrow, E.M. Antman, A. Charlesworth, and et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
12. S.V. Rao, L.A. McCoy, J.A. Spertus, and et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry J Am Coll Cardiol Intv 6 2013 897 904
13. R. Mehran, U. Baber, P.G. Steg, and et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Lancet 382 2013 1714 1722
14. D.E. Cutlip, S. Windecker, R. Mehran, and et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. K. Thygesen, J.S. Alpert, A.S. Jaffe, and et al. Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
16. R. Mehran, S.V. Rao, D.L. Bhatt, and et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
17. B.C. Astor, P. Muntner, A. Levin, J.A. Eustace, and J. Coresh Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 2002 1401 1408
18. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
19. A.M. Wood, I.R. White, and P. Royston How should variable selection be performed with multiply imputed data? Stat Med 27 2008 3227 3246
20. D.B. Rubin Multiple Imputation for Nonresponse in Surveys 1987 John Wiley New York
21. L.M. Sullivan, J.M. Massaro, and R.B. D'Agostino Sr. Presentation of multivariate data for clinical use: the Framingham study risk score functions Stat Med 23 2004 1631 1660
22. G.W. Stone, B. Witzenbichler, G. Weisz, and et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Lancet 382 2013 614 623
23. P. Genereux, G. Giustino, B. Witzenbichler, and et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention J Am Coll Cardiol 66 2015 1036 1045
24. G. Ducrocq, J.S. Wallace, G. Baron, and et al. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis Eur Heart J 31 2010 1257 1265
25. Yeh RW, Secemsky EA, Kereiakes DJ, et al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA 2016 [E-pub ahead of print].
26. D.P. Faxon, J.W. Eikelboom, P.B. Berger, and et al. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary Circ Cardiovasc Interv 4 2011 522 534
27. P.M. Ho, P.N. Peterson, and F.A. Masoudi Evaluating the evidence: is there a rigid hierarchy? Circulation 118 2008 1675 1684
28. R. Waksman, A.J. Kirtane, R. Torguson, and et al. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis) J Am Coll Cardiol Intv 7 2014 1093 1102
29. B.F. Gage, A.D. Waterman, W. Shannon, and et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
30. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
31. M.W. Sherwood, S.D. Wiviott, S.A. Peng, and et al. Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry J Am Heart Assoc 3 2014 e000849
32. A.V.C.L.B.R.H. Sahlen, L. Wallentin, S.K. James, and T. Jernberg Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) Eur Heart J Cardiovasc Pharmacother 2015 1 8
33. C.E. Strauss, B.R. Porten, I.J. Chavez, and et al. Real-time decision support to guide percutaneous coronary intervention bleeding avoidance strategies effectively changes practice patterns Circ Cardiovasc Qual Outcomes 7 2014 960 967